|
|
|
Corporate Profile: RXi Pharmaceuticals
| Summary: |
RXi Pharmaceuticals is focused on the development and commercialization of therapeutics using RNA interference (RNAi).
|
| Address (HQ): |
257 Simarano Drive
Suite 101
Marlborough, MA 01752
|
| Phone #'s (HQ): |
| Main |
(508) 767-3861 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
(508) 767-3862 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| RXII |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
